| Dr John Reid Mcbryde, DPT | |
|
833 Saint Vincents Dr, Pob 111, Suite 205, Birmingham, AL 35205-1606 | |
| (205) 939-0133 | |
| Not Available |
| Full Name | Dr John Reid Mcbryde |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 16 Years |
| Location | 833 Saint Vincents Dr, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063664761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PTH5333 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ati Holdings Of Alabama Llc | 2769756436 | 63 |
News Archive
Wellcome Trust Sanger Institute scientists have developed a new large-scale method to identify the interactions between proteins that are a major target for therapeutic intervention.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reports a financial update as of June 30, 2010. In addition, the Company provides a progress update of its MARINE and ANCHOR trials, the two on-going Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.
Research conducted by the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences provides evidence to support expansion of insurance plan coverage of noninvasive prenatal testing (NIPT), a simple maternal blood draw which screens for fetal chromosomal disorders including trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome), and trisomy 21 (Down syndrome), to women under the age of 35.
With a nudge from the new health care law and pressure from Medicare, hospitals, doctors and nurses are struggling to prepare for explosive growth in the numbers of high-risk elderly patients. More than 40 percent of adult patients in acute care hospital beds are 65 or older. Seventy million Americans will have turned 65 by 2030.
› Verified 6 days ago
| Provider Name | Orthosports Associates Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114226438 PECOS PAC ID: 3173707171 Enrollment ID: O20110418000109 |
News Archive
Wellcome Trust Sanger Institute scientists have developed a new large-scale method to identify the interactions between proteins that are a major target for therapeutic intervention.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reports a financial update as of June 30, 2010. In addition, the Company provides a progress update of its MARINE and ANCHOR trials, the two on-going Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.
Research conducted by the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences provides evidence to support expansion of insurance plan coverage of noninvasive prenatal testing (NIPT), a simple maternal blood draw which screens for fetal chromosomal disorders including trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome), and trisomy 21 (Down syndrome), to women under the age of 35.
With a nudge from the new health care law and pressure from Medicare, hospitals, doctors and nurses are struggling to prepare for explosive growth in the numbers of high-risk elderly patients. More than 40 percent of adult patients in acute care hospital beds are 65 or older. Seventy million Americans will have turned 65 by 2030.
› Verified 6 days ago
| Provider Name | Ati Holdings Of Alabama Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1063952646 PECOS PAC ID: 2769756436 Enrollment ID: O20170919001462 |
News Archive
Wellcome Trust Sanger Institute scientists have developed a new large-scale method to identify the interactions between proteins that are a major target for therapeutic intervention.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reports a financial update as of June 30, 2010. In addition, the Company provides a progress update of its MARINE and ANCHOR trials, the two on-going Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.
Research conducted by the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences provides evidence to support expansion of insurance plan coverage of noninvasive prenatal testing (NIPT), a simple maternal blood draw which screens for fetal chromosomal disorders including trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome), and trisomy 21 (Down syndrome), to women under the age of 35.
With a nudge from the new health care law and pressure from Medicare, hospitals, doctors and nurses are struggling to prepare for explosive growth in the numbers of high-risk elderly patients. More than 40 percent of adult patients in acute care hospital beds are 65 or older. Seventy million Americans will have turned 65 by 2030.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Reid Mcbryde, DPT 833 St. Vincent Drive, Pob 111, Suite 205, Birmingham, AL 35205 Ph: (205) 939-0133 | Dr John Reid Mcbryde, DPT 833 Saint Vincents Dr, Pob 111, Suite 205, Birmingham, AL 35205-1606 Ph: (205) 939-0133 |
News Archive
Wellcome Trust Sanger Institute scientists have developed a new large-scale method to identify the interactions between proteins that are a major target for therapeutic intervention.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reports a financial update as of June 30, 2010. In addition, the Company provides a progress update of its MARINE and ANCHOR trials, the two on-going Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.
Research conducted by the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences provides evidence to support expansion of insurance plan coverage of noninvasive prenatal testing (NIPT), a simple maternal blood draw which screens for fetal chromosomal disorders including trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome), and trisomy 21 (Down syndrome), to women under the age of 35.
With a nudge from the new health care law and pressure from Medicare, hospitals, doctors and nurses are struggling to prepare for explosive growth in the numbers of high-risk elderly patients. More than 40 percent of adult patients in acute care hospital beds are 65 or older. Seventy million Americans will have turned 65 by 2030.
› Verified 6 days ago
Ms. Jenesis C. Safford, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 19th St S, Room 8307, Birmingham, AL 35233 Phone: 205-933-4390 | |
Jason Cooper Grammer, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3125 Independence Dr, Suite 300b, Birmingham, AL 35209 Phone: 205-879-7501 Fax: 205-879-0675 | |
Samantha Specht, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-638-7763 | |
Ms. Robin Vanchina, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3125 Independence Dr, 300b, Birmingham, AL 35209 Phone: 205-879-7501 Fax: 205-879-0675 | |
James Wallace Henry, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1801 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-228-7631 | |
Jennifer Joseph Smith, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Mr. Walter Randall Mackey, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 144 Narrows Point Ct, Birmingham, AL 35242 Phone: 205-981-1197 Fax: 205-981-1197 |